X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1425) 1425
Book Review (387) 387
Publication (109) 109
Web Resource (9) 9
Book Chapter (6) 6
Magazine Article (5) 5
Book / eBook (3) 3
Conference Proceeding (2) 2
Data Set (1) 1
Dissertation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1191) 1191
humans (1140) 1140
osteoporosis (888) 888
female (851) 851
teriparatide (841) 841
teriparatide - therapeutic use (790) 790
bone density conservation agents - therapeutic use (699) 699
postmenopausal women (546) 546
endocrinology & metabolism (518) 518
osteoporosis - drug therapy (506) 506
aged (490) 490
middle aged (436) 436
bone density - drug effects (416) 416
male (410) 410
parathyroid hormone (360) 360
fractures (346) 346
orthopedics (346) 346
bone-mineral density (337) 337
osteoporosis, postmenopausal - drug therapy (335) 335
alendronate (309) 309
animals (280) 280
medicine & public health (265) 265
parathyroid-hormone (248) 248
bone density (241) 241
diphosphonates - therapeutic use (235) 235
bisphosphonates (220) 220
aged, 80 and over (218) 218
drug therapy (216) 216
endocrinology (206) 206
rheumatology (206) 206
teriparatide - administration & dosage (201) 201
treatment outcome (198) 198
teriparatide - pharmacology (186) 186
bones (185) 185
risk factors (182) 182
therapy (180) 180
parathyroid-hormone 1-34 (175) 175
bone mineral density (173) 173
rats (163) 163
women (161) 161
bone density conservation agents - administration & dosage (160) 160
parathyroid hormone - therapeutic use (159) 159
density (157) 157
care and treatment (153) 153
denosumab (152) 152
bone density conservation agents - pharmacology (145) 145
risk (145) 145
bone density conservation agents - adverse effects (142) 142
abridged index medicus (140) 140
medicine, general & internal (138) 138
teriparatide - adverse effects (138) 138
research (131) 131
fractures, bone - prevention & control (129) 129
adult (125) 125
health aspects (125) 125
postmenopausal osteoporosis (124) 124
analysis (118) 118
alendronate - therapeutic use (117) 117
fracture (116) 116
pth (111) 111
osteoporosis - complications (110) 110
pharmacology & pharmacy (110) 110
mineral density (108) 108
prevention (108) 108
drug therapy, combination (107) 107
bone remodeling - drug effects (106) 106
osteoporosis - physiopathology (104) 104
vertebral fractures (104) 104
bone and bones - drug effects (101) 101
zoledronic acid (101) 101
bone (99) 99
vertebral fracture (98) 98
osteoporotic fractures - prevention & control (94) 94
medicine, research & experimental (87) 87
hormone replacement therapy (85) 85
strontium ranelate (85) 85
parathyroid hormone - pharmacology (82) 82
vitamin d (82) 82
biochemical markers (81) 81
drug administration schedule (81) 81
osteogenesis - drug effects (81) 81
glucocorticoid-induced osteoporosis (80) 80
time factors (80) 80
internal medicine (79) 79
biomarkers - blood (77) 77
injections, subcutaneous (76) 76
mass (75) 75
osteoporosis, postmenopausal - complications (75) 75
calcium (74) 74
absorptiometry, photon (73) 73
bone and bones - metabolism (73) 73
osteoporosis, postmenopausal - physiopathology (73) 73
surgery (71) 71
fractures, bone - etiology (69) 69
raloxifene (69) 69
glucocorticoids - adverse effects (68) 68
men (68) 68
vitamin d - therapeutic use (68) 68
double-blind (67) 67
hip fracture (67) 67
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1333) 1333
Japanese (33) 33
French (25) 25
German (23) 23
Spanish (9) 9
Chinese (4) 4
Dutch (4) 4
Italian (4) 4
Croatian (3) 3
Danish (3) 3
Hungarian (2) 2
Czech (1) 1
Finnish (1) 1
Norwegian (1) 1
Polish (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
JAMA, ISSN 0098-7484, 08/2016, Volume 316, Issue 7, pp. 722 - 733
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2016, Volume 375, Issue 16, pp. 1532 - 1543
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 503 - 511
Clinical data suggest concomitant therapy with bisphosphonates and parathyroid hormone (PTH) may blunt the anabolic effect of PTH; rodent models suggest that... 
ZOLEDRONIC ACID | INFUSION | TERIPARATIDE | BISPHOSPHONATE | OSTEOPOROSIS | Bisphosphonate | teriparatide | infusion | osteoporosis | zoledronic acid | BONE-MINERAL DENSITY | PARATHYROID-HORMONE 1-34 | ALENDRONATE | WOMEN | FRACTURE | BISPHOSPHONATES | THERAPY | CANCELLOUS BONE | MASS | ENDOCRINOLOGY & METABOLISM | PROXIMAL FEMUR | Collagen Type I - blood | Peptides - blood | Injections, Intravenous | Teriparatide - therapeutic use | Bone Density - physiology | Follow-Up Studies | Humans | Middle Aged | Osteoporosis, Postmenopausal - complications | Imidazoles - administration & dosage | Osteoporotic Fractures - drug therapy | Bone Remodeling - physiology | Injections, Subcutaneous | Peptide Fragments - blood | Diphosphonates - therapeutic use | Female | Imidazoles - therapeutic use | Drug Therapy, Combination | Osteoporotic Fractures - physiopathology | Diphosphonates - adverse effects | Biomarkers - metabolism | Bone Density Conservation Agents - adverse effects | Teriparatide - administration & dosage | Imidazoles - adverse effects | Bone Density Conservation Agents - therapeutic use | Diphosphonates - administration & dosage | Procollagen - blood | Bone Density Conservation Agents - administration & dosage | Osteoporosis, Postmenopausal - drug therapy | Osteoporosis, Postmenopausal - blood | Osteoporotic Fractures - complications | Least-Squares Analysis | Osteoporosis, Postmenopausal - physiopathology | Teriparatide - adverse effects | Aged | Osteoporotic Fractures - blood | Index Medicus
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 386, Issue 9999, pp. 1147 - 1155
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2014, Volume 370, Issue 5, pp. 412 - 420
Journal Article